Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function.
about
Current and emerging treatment strategies for Duchenne muscular dystrophyCardiac involvement in Duchenne and Becker muscular dystrophyCurrent understanding of molecular pathology and treatment of cardiomyopathy in duchenne muscular dystrophyReview of Journal of Cardiovascular Magnetic Resonance 2013Review of Journal of Cardiovascular Magnetic Resonance 2014.Dystrophic Cardiomyopathy-Potential Role of Calcium in Pathogenesis, Treatment and Novel TherapiesPatterns of late gadolinium enhancement in Duchenne muscular dystrophy carriers.Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophy.Evaluation of post-contrast myocardial t1 in duchenne muscular dystrophy using cardiac magnetic resonance imaging.Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophyDuchenne Muscular Dystrophy Mice and Men: Can Understanding a Genetic Cardiomyopathy Inform Treatment of Other Myocardial Diseases?Unique pattern of late gadolinium enhancement on cardiac magnetic resonance imaging in Duchenne muscular dystrophy.Native T1 values identify myocardial changes and stratify disease severity in patients with Duchenne muscular dystrophy.Upper arm and cardiac magnetic resonance imaging in Duchenne muscular dystrophy.Magnetic Resonance Monitoring of Disease Progression in mdx Mice on Different Genetic Backgrounds.Cardiac profile of asymptomatic children with Becker and Duchenne muscular dystrophy under treatment with steroids and with/without perindopril.Utility of late gadolinium enhancement in pediatric cardiac MRI.Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?Cardiac Involvement Classification and Therapeutic Management in Patients with Duchenne Muscular Dystrophy.Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophyProgression of Duchenne Cardiomyopathy Presenting with Chest Pain and Troponin Elevation.Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy.Myocardial Strain Using Cardiac MR Feature Tracking and Speckle Tracking Echocardiography in Duchenne Muscular Dystrophy Patients.Clinical Manifestations and Overall Management Strategies for Duchenne Muscular Dystrophy.Elevated Myocardial Extracellular Volume Fraction in Duchenne Muscular Dystrophy.Evaluation of cardiac functions in children with Duchenne Muscular Dystrophy: A prospective case-control study.Free-breathing motion-corrected late-gadolinium-enhancement imaging improves image quality in children.Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics.Progressive left ventricular dysfunction and long-term outcomes in patients with Duchenne muscular dystrophy receiving cardiopulmonary therapies.Regional circumferential strain is a biomarker for disease severity in duchenne muscular dystrophy heart disease: a cross-sectional study
P2860
Q26741535-2CDE9A08-5993-4A04-ADA9-C60848F5509DQ26801616-AF45F3D6-F505-448D-A7AF-3A168B388E98Q28082625-0A0CAA50-29B2-470F-B94C-BF1499EBB7EAQ30487473-D6916D87-C293-45F4-A806-F148137AA474Q30488573-3692BC0F-23D3-4FF6-BDF1-F0034453160EQ33608478-C60F4C18-C06D-4C58-9148-2491B68633D7Q33895261-862AD29E-875A-480C-86C1-DFB32F067B9FQ34315276-8DF48361-AAD5-4381-9CFD-BB0EFE844524Q35629034-80F1E05F-4796-4D90-ADF5-6AE9D6EEF0C6Q36069707-9D6A299F-40EF-45B6-B2D8-47E81807750FQ36489696-3D74B436-0F12-4062-95C9-A582DDEE31DEQ36760550-FF27F56E-D9A4-491B-83F8-8AAA840C33BAQ36903533-60F9BE4F-7AED-4C1A-894E-7CF8D67B9427Q37374426-E2E04C89-9D66-455B-91AC-C89D00A9387BQ37577885-2A9D7274-0D7C-47E7-9F9A-0E740FEEBF4AQ38615889-867A56C3-14D5-4D7A-B6C9-0C818B1369CFQ38664358-751DD6F0-FA69-4CEA-B41A-5F2C8C98CBF3Q38683303-26C5583A-37FB-42F9-9EEB-60145F89D993Q39010745-FB5BB35F-FCCD-4CAA-8037-50931F914327Q39166732-66455216-18D3-4B0D-A277-6EEC803AA18AQ41151699-60ED3E01-D7A5-41F2-8FBC-CA95B3D770D4Q41922953-D13D40B0-4893-440C-A22F-4C4950719509Q45069359-3ED0F014-AE5F-475C-A347-B6FF9BA4FE83Q47393949-DE34D6A4-734B-4ABF-A62F-8B6446A2C51FQ47669192-5AE4564E-4550-4C66-AFBB-D1007238FBC9Q48315994-9AFEC7FF-B69B-41EC-B85D-78D20F4ECA23Q49164127-33B5301A-AA1C-44C3-905B-5C1C337AA7D3Q51546363-8E7FAC2F-0395-4BB3-80AE-3B42C8C0D826Q52372774-EBB53384-A443-4AD7-990C-B5AE9027F513Q53837961-CB28D9C2-EAFB-42A9-B40E-FCA0E9F214ADQ57161630-9F57B00C-6BC8-44AA-9DB9-E789D9E32D44
P2860
Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevalence and distribution of ...... ventricular systolic function.
@en
Prevalence and distribution of ...... ventricular systolic function.
@nl
type
label
Prevalence and distribution of ...... ventricular systolic function.
@en
Prevalence and distribution of ...... ventricular systolic function.
@nl
prefLabel
Prevalence and distribution of ...... ventricular systolic function.
@en
Prevalence and distribution of ...... ventricular systolic function.
@nl
P2093
P2860
P356
P1476
Prevalence and distribution of ...... ventricular systolic function.
@en
P2093
D Woodrow Benson
Hussein R Al-Khalidi
Linda H Cripe
Michael D Taylor
Robert O'Donnell
Subha V Raman
Wojciech Mazur
P2860
P2888
P356
10.1186/1532-429X-15-107
P577
2013-12-21T00:00:00Z
P6179
1003860108